Tandem Diabetes Care, Inc.
TNDM
|
$31.75
-3.67%
-3.78%
1.1M
|
Health Technology
(0.0% 1d) (3.1% 1m) (-23.0% 1y) (0.0% 2d) (-3.7% 3d) (-5.2% 7d) (-35.56% volume)
Earnings Calendar: 2024-02-21
Market Cap: $ 2,049,890,363
http://www.tandemdiabetes.com
Sec Filling | Patents | 1043 employees
(US) Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.
insulin diabetes diabetic msa
add to watch list Paper trade email alert is off
Press-releases
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
Published: 2024-04-09 (Crawled : 00:00) - biospace.com/
TNDM | $31.75 -3.67% -3.78% 1.1M
|
Health Technology
|
| O: 0.3%
H: 4.7%
C: 3.68%
first care diabetes financial results
Parexel Announces CEO Succession PlanChief Operating & Growth Officer Peyton Howell to succeed Jamie Macdonald effective May 15, 2024
Published: 2024-03-18 (Crawled : 15:00) - biospace.com/
TNDM | $31.75 -3.67% -3.78% 1.1M
|
Health Technology
|
| O: 0.7%
H: 8.21%
C: 7.98%
ceo growth
Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029
Published: 2024-03-06 (Crawled : 11:00) - biospace.com/
TNDM | $31.75 -3.67% -3.78% 1.1M
|
Health Technology
|
| O: -0.39%
H: 2.61%
C: 0.26%
million care diabetes
Digital Diabetes Management Market to reach over USD 49.5 Bn by the year 2031 - Explained Details | Exclusive Study by InsightAce Analytic
Published: 2024-02-21 (Crawled : 10:00) - prnewswire.com
ABT | News | $105.9 -3.03% 0.38% 11M
|
Health Technology
|
| O: 2.37%
H: 0.0%
C: 0.0%
TNDM | $31.75 -3.67% -3.78% 1.1M
|
Health Technology
|
| O: -1.8%
H: 0.89%
C: -2.53%
PODD | $166.26 -3.74% -3.89% 690K
|
Health Technology
|
| O: -1.15%
H: 1.54%
C: 1.31%
management year reach diabetes study market
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance
Published: 2024-02-21 (Crawled : 00:00) - biospace.com/
TNDM | $31.75 -3.67% -3.78% 1.1M
|
Health Technology
|
| O: -1.8%
H: 0.89%
C: -2.53%
year care diabetes financial results
Wearable Injectors Market Worth $15.1 Billion | MarketsandMarkets™
Published: 2024-02-09 (Crawled : 15:30) - prnewswire.com
MDT | News | $79.08 -0.22% 0.25% 4.6M
|
Health Technology
|
| O: -0.12%
H: 0.09%
C: -1.27%
ABBV | $164.25 1.05% 0.26% 3M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
UTHR | $235.31 1.52% 1.55% 370K
|
Health Technology
|
| O: 0.18%
H: 0.11%
C: 0.1%
TNDM | $31.75 -3.67% -3.78% 1.1M
|
Health Technology
|
| O: 0.22%
H: 1.06%
C: 0.34%
MNKD | $4.1 1.23% 1.34% 2.5M
|
Health Technology
|
| O: 1.46%
H: 0.86%
C: 0.86%
PODD | $166.26 -3.74% -3.89% 690K
|
Health Technology
|
| O: 0.14%
H: 0.28%
C: -2.21%
AMGN | $264.07 -0.59% -0.59% 350
|
Health Technology
|
| O: 0.0%
H: 0.05%
C: -1.27%
market
Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook
Published: 2024-01-24 (Crawled : 12:30) - prnewswire.com
ABT | News | $105.9 -3.03% 0.38% 11M
|
Health Technology
|
| O: -3.45%
H: 0.0%
C: 0.0%
TNDM | $31.75 -3.67% -3.78% 1.1M
|
Health Technology
|
| O: 0.79%
H: 2.14%
C: 1.14%
financial
Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor
Published: 2024-01-08 (Crawled : 14:00) - biospace.com/
ABT | News | $105.9 -3.03% 0.38% 11M
|
Health Technology
|
| O: 0.36%
H: 0.0%
C: 0.0%
TNDM | $31.75 -3.67% -3.78% 1.1M
|
Health Technology
|
| O: 0.07%
H: 3.06%
C: 1.73%
libre first freestyle sensor system diabetes plus insulin
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in U.S.
Published: 2023-12-06 (Crawled : 15:30) - biospace.com/
TNDM | $31.75 -3.67% -3.78% 1.1M
|
Health Technology
|
| O: 1.8%
H: 6.69%
C: 3.2%
integration software care diabetes insulin
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - BCLI
Published: 2023-11-08 (Crawled : 00:00) - prnewswire.com
PAYC 4 | $186.86 -1.73% 0.08% 820K
|
Technology Services
|
| O: 1.06%
H: 0.95%
C: -0.91%
TNDM | $31.75 -3.67% -3.78% 1.1M
|
Health Technology
|
| O: 0.0%
H: 1.8%
C: -5.54%
BCLI | $0.5408 2.6% 2.73% 2.2K
|
Health Technology
|
| O: -1.28%
H: 2.06%
C: -4.47%
trusted deadline cell therapeutics
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 49.67% 1.4M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
HOLO | $2.24 -5.49% 27.74% 7.7M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
VIAO | $0.262 0.77% 16.03% 14M
|
Electronic Technology
DXF | $0.2708 -5.71% 14.48% 190K
|
Finance
GRFX | $0.2159 -10.04% 12.55% 5.9K
|
n/a
BHIL | $0.1722 -3.8% 12.08% 290K
|
Agriculture, Forestry, Fishing ...
ANVS | $8.99 -10.81% 10.9% 270K
|
Health Technology
Last 48 Hours Insiders Buying
IZEA | $2.53 1.2% -2.4% 0
|
Technology Services
|
00:00
RKT P 383 | $11.38 -0.52% 1.58% 1.4M
|
Finance
|
22:30
CTRN P 18090 | $22.37 -1.41% -1.02% 0
|
Retail Trade
|
22:00
BRN P 10650 | $2.79 2.2% 0.0% 35K
|
Energy Minerals
|
21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M
|
Health Technology
|
16:30
RMCF | $3.53 -3.16% -3.85% 3.8K
|
Consumer Non-Durables
|
20:10